Modafinil effects in multiple sclerosis patients with fatigue.

Area of Science:

• Neurology
• Neuroscience
• Pharmacology

Background:

• Multiple sclerosis (MS) is a chronic neurological disease.
• Fatigue is a common and debilitating symptom in MS patients.
• Cognitive and motor impairments often accompany MS fatigue.

Purpose of the Study:

• To evaluate the efficacy of Modafinil (MOD) in improving focused attention, motor function, and motor cortex excitability in MS patients experiencing fatigue.
• To compare the effects of MOD against a placebo (PL) in a double-blind, controlled study.

Main Methods:

• A double-blind, placebo-controlled study involving 21 MS patients with fatigue.
• Participants received either MOD or PL for 8 weeks.
• Cognitive function (d2 alertness test), dexterity (Nine Hole Peg Test), and motor excitability (transcranial magnetic stimulation techniques) were assessed at baseline, after initial drug intake, and after 8 weeks.

Main Results:

• Modafinil significantly improved fatigue, focused attention, and dexterity compared to placebo.
• MS patients taking MOD made fewer errors on cognitive tests and performed dexterity tasks faster.
• Transcranial magnetic stimulation revealed increased motor evoked potential amplitudes in the MOD group, indicating enhanced motor cortex excitability.

Conclusions:

• Modafinil demonstrates potential as a therapeutic agent for MS patients suffering from fatigue.
• MOD can improve cognitive functions, enhance motor skills, and modulate motor cortex excitability in this patient population.
• Further research is warranted to confirm these findings and establish optimal treatment protocols.